Class Action InvestigationsZantac Class ActionZantac Lawsuits against Drug Manufacturers in Canada
November 23, 2020by Shamis & Gentile P.A.
Health Canada instructed companies to stop distributing ranitidine drugs in Canada in September 2019 while it assessed the risk of impurity and probable carcinogen called NDMA (N-nitrosodimethylamine) detected in some drugs. Why were ranitidine medications like Zantac recalled by Health Canada? The companies have since recalled products from the Canadian market because they contained or […]